• $675.00


Description :Rabbit Polyclonal Antibody

Species :

Tag :

Expression System:

Sequence :

Specificity  :Recognizes the 35kDa CDK5 (p31) protein

Cited Applications :ELISA, IP, WB
Ideal working dilutions for each application should be empirically determined by the investigator.

Cross Reactivity :Human, Rat and Mouse

Host Isotype / Clone# :Rabbit, Antiserum

Immunogen :The antibody was produced against synthesized peptide corresponding to the C-Terminus of human CDK5 protein conjugated to KLH.

Purification :Delipidation and defibrination

Stability :1yr at –20oC from date of shipment

Sample Data :Anti-CDK5 antibody was diluted 1:500 to detect CDK5 in human brain cortex tissue. Tissue was formalin fixed and paraffin embedded. No pre-treatment of sample was required. The image shows the localization of antibody as the precipitated red signal, with a hematoxylin purple nuclear counter stain.

Scientific Background :The neuronal protein kinase, CDK5 is implicated in a vast array of normal neuronal functions including regulation of neurotransmitter synthesis (1), the presynaptic vesicle cycle (2), neurotransmitter receptor trafficking, and dopamine neurotransmission (3). CDK5 is active as a heterodimer with a 25 kDa protein. The 25 kDa protein is derived proteolytically from a 35 kDa brain and neuron-specific precursor protein (4). CDK5 phosphorylates a diverse list of substrates and has been implicated in a wide range of neurological and neuropsychiatric disorders, which include Alzheimer’s, Parkinson’s, Huntington’s, epilepsy, schizophrenia, and drug addiction (5).

References :
1. Kansy, J. et al. Identification of tyrosine hydroxylase as a physiological substrate of Cdk5. J. Neurochem. 2004 91, 374-384. 

2. Nguyen, C. et al: Cdk5 and the mystery of synaptic vesicle endocytosis. J Cell Biol. 2003 163, 697- 699.  Bibb, J A. et al. Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signaling in neurons. Nature 1999 402, 669-671. 

3. Tang, D. et al: Cyclin-dependent kinase 5 (Cdk5) and neuron-specific Cdk5 activators. Prog Cell Cycle Res. 1996;2:205-16. 

4. Dhavan, R. et al: A decade of CDK5. Nat Rev Mol Cell Biol. 2001 Oct;2(10):749-59.

Product Sheets (By Lot #) :


Research Areas :Cancer, Cell Cycle, Ser/Thr Kinases